The NMDA (N-methyl-D-aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: A double-blind, placebo-controlled study

European Journal of Pain

Volumn 2, Issue 4, 1998, Pages 321-327

  Eisenberg, Elon ^a,b   Kleiser, Ana ^a   Dortort, Ariela ^a   Haim, Tamar ^a   Yarnitsky, David ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DIPYRONE; KETAMINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO;

ADULT; ALLODYNIA; ANALGESIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HERPES SIMPLEX; HUMAN; MALE; NEURALGIA; PAIN ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TREATMENT OUTCOME; VERTIGO;

EID: 0032410484     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3801(98)90030-1     Document Type: Article

References (35)

1. Backonja M, Arndt G, Gombar KA, Check B, Zimmerman M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994; 56: 51-57.
2. Bormann J. Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol 1989; 166: 591-592.
3. Byas-Smith MG, Max MB, Gracely RH, Bennett GJ. Intravenous ketamine and alfentanil in patients with causalgic pain and allodynia. VIIth World Congress on Pain 1993; 454-455.
4. Carlton SM, Hargett GL. Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats. Neurosci Lett 1995; 198: 115-118.
5. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of the clinical and experimental evidence. Pain 1993; 52: 259-285.
6. Dahl JB, Brennum J, Arednt-Nielsen L, Jensen TS, Kehlet H. The effect of pre- versus post-injury infiltration with lidocaine on thermal and mechanical hyperalgesia after heat injury to the skin. Pain 1993; 53: 43-51.
7. Davar G, Hamma A, Deykin A, Vos B, Maciewicz R. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy. Brain Res 1992; 553: 327-330.
8. Davis SN, Lodge D. Evidence for involvement of N-methyl-D-aspartic acid receptors in 'wind up' of class 2 neurons in the dorsal horn of the rat. Brain Res 1987; 424: 402-406.
9. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in frequency dependent potentiation of deep dorsal horn neurons following c-fiber stimulation. Neuropharmacol 1987; 26: 1235-1238.
10. Dubner R, Ruda MA. Activity dependent neural plasticity following tissue injury and inflammation. Trends Neurosci 1992; 14: 96-103.
11. Eide PK, Jorum E, Stubhaug A, Bermnes J, Breivik H. Relief of post-herpetic neuralgia with N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 1994; 58: 347-354.
12. Eide PK, Stubhaug A, Stenehjem EA. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurg 1995a; 37: 1080-1087.
13. Eide PK, Stubhaug A, Oye I, Breivik H. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain 1995b; 61: 221-228.
14. Eisenberg E, Vos BP, Strassman AM. The NMDA receptor antagonist memantine blocks pain behavior in a rat model of formalin-induced facial pain. Pain 1993; 54: 301-307.
15. Eisenberg E, LaCross S, Strassman AM. The prophylactic and therapeutic efficacy of the clinically tested NMDA receptor antagonist memantine in a rat model of carrageenan-induced thermal hyperalgesia. Eur J Pharmacol 1994; 225: 123-129.
16. Eisenberg E, LaCross S, Strassman AM. The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy. Neurosci Lett 1995; 187: 17-20.
17. Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain 1995; 64: 283-291.
18. Frost SA, Raja SN, Campbell JN, Mayer RA, Khan AA. Does hyperalgesia to cooling stimuli characterize patients with sympathetically maintained pain (reflex sympathetic dystrophy)? In: Dubner R, Gebhart GF, Bond MR, editors. Proceedings of the Vth World Congress of Pain. Amsterdam: Elsevier, 1988: 151-156.
19. Gurtelmeyer R, Erbler H. Memantine in the treatment of mild to moderate dementia syndrome. Arzneimittle-Forschung/Drug Research 1992; 42: 904-913.
20. Jensen MP, Karoly P. Self-report scales and procedures for assessing pain in adults. In: Turk DC, Melzack R, editors. Handbook of Pain Assessment. New York: The Guilford Press, 1992: 135-151.
21. Kristenson JD, Svensson B Gordth T Jr. The NMDA receptor antagonists CPP abolishes neurogenic 'windup pain' after intrathecal administration in humans. Pain 1992; 51: 249-253.
22. Lehr R. Sixteen squared over d squared: a relation for crude s estimates. Stat Med 1992; 11: 1099-1102.
23. Loeser JD. Herpes zoster and postherpetic neuralgia. Pain 1986; 25: 149-164.
24. Mao J, Price DD, Hayes RL, Mayer DJ, Frenk H. Intrathecal treatment with dextrorphan or ketamine patently reduces pain-related behaviors in a rat model of peripheral mononeuropathy. Brain Res 1993; 605: 164-168.
25. Mathisen LC, Skjelbred P, Skoglund LA, Oye I. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain 1995; 61: 215-220.
26. Melzack R. The McGill Pain Questionnaire. Pain 1975; 1: 272-299.
27. Nelson KA, Park KM, Robinovitz E, Tsigos C, Max BM. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997; 48: 1212-1218.
28. Neugebauer V, Kornhuber J, Lucke T, Schaible HG. The clinically available NMDA receptor antagonist memantine is antinociceptive on rat spinal neurons. NeuroReport 1993; 4: 1259-1262.
29. Persson J, Axelsson G, Hallin RG, Gustafsson L. Beneficial effects of ketamine in chronic pain state with allodynia possibly due to central sensitization. Pain 1995; 60: 217-222.
30. Price DD, MeGrath PA, Rafii A, Buckingham B. The validation of the Visual Analogue Scale as ratio scale measures for chronic and experimental pain. Pain 1983; 17: 45-46.
31. Tal M, Bennet GJ. Dextrometorphan relieves neuropathic heat-evoked hyperalgesia. Neurosci Lett 1993; 151: 107-110.
32. Watson CPN, Evans RJ, Watt VR, Birkett N. Post-herpetic neuralgia: 208 cases. Pain 1988; 35: 289-297.
33. Yamamoto T, Yaksh TL. Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK-801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 1992; 77: 757-763.
34. Yarnitsky D, Sprecher E, Zaslansky R, Hemly JA. Heat pain: normative data and repeatability. Pain 1995; 60: 329-332.
35. Zeltzer Z, Cohn S, Ginzburg R, Beilin B. Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge. Pain 1991; 45: 69-75.